Advertisement

The evolution of myocardium at risk by T2-STIR MR imaging the first week after acute myocardial ischemia

  • David Nordlund
  • Gert Klug
  • Einar Heiberg
  • Sasha Koul
  • Terje H Larsen
  • Pavel Hoffmann
  • Bernhard Metzler
  • David Erlinge
  • Dan Atar
  • Anthony H Aletras
  • Marcus Carlsson
  • Henrik Engblom
  • Håkan Arheden
Open Access
Poster presentation
  • 243 Downloads

Keywords

Myocardial Infarction Percutaneous Coronary Intervention Acute Myocardial Infarction Infarct Size Cardiac Magnetic Resonance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Background

Myocardial salvage is currently being used as endpoint in several clinical trials and is determined by relating final infarct size to myocardium at risk (MaR). T2-weighted imaging (T2-STIR) cardiac magnetic resonance (CMR) has previously been shown to enable assessment of MaR up to one week after acute myocardial infarction. Recent experimental data indicate that the extent of MaR by T2-STIR varies over the first week which would have implications on how to design clinical cardioprotection trials using myocardial salvage as endpoint and in the clinical diagnosis of patients with myocardial infarction and normal coronary arteries.

To investigate whether MaR as assessed by T2-STIR differs depending on scan day during the first week after the acute event in patients with reperfused first-time myocardial infarction.

Methods

196 STEMI-patients from the MITOCARE and CHILL-MI trials undergoing acute percutaneous coronary intervention were included in the study. Eight additional patients with CMR on day 1 were also included. T2-STIR MR imaging was performed 1-7 days after the acute event and was used to evaluate MaR. Diagnostic quality on a scale from 0-3 and ability to correctly assign culprit vessel compared to angiography.

Results

There was no significant difference in MaR over the first week (p = 0.44, Figure 1A) neither was there any change in diagnostic quality (p = 0.26, Figure 1B). The rate of correctly assigned culprit vessel was also similar for the different scan days (Figure 1C).
Figure 1

MaR by T2-STIR over the first week. A) MaR as % of LV mass over time; B) diagnostic image quality over time; and C) Ratio of correctly assigned culprit vessel compared to angiography over time. Note that there is no significant change in MaR during the first week in any of the above aspects. Open and closed circles show mean values of MaR by CE-SSFP and T2-STIR respectively. Error bars show 1 standard deviation. MaR=Myocardium at risk, LV=Left ventricular mass, T2-STIR= T2-weighted short tau inversion recovery, CE-SSFP = contrast enhanced steady state free precession, LGE=late gadolinium enhancement.

Conclusions

Myocardium at risk by T2-STIR CMR imaging do not change in humans over the first week after acute reperfused myocardial infarction suggesting that MaR is a stable measure during this period of time.

Copyright information

© Nordlund et al. 2016

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • David Nordlund
    • 1
  • Gert Klug
    • 2
  • Einar Heiberg
    • 1
    • 3
  • Sasha Koul
    • 4
  • Terje H Larsen
    • 5
    • 6
  • Pavel Hoffmann
    • 9
  • Bernhard Metzler
    • 2
  • David Erlinge
    • 4
  • Dan Atar
    • 7
  • Anthony H Aletras
    • 1
    • 8
  • Marcus Carlsson
    • 1
  • Henrik Engblom
    • 1
  • Håkan Arheden
    • 1
  1. 1.Department of Clinical Physiology, Clinical SciencesLund UniversityLundSweden
  2. 2.University Clinic of Internal Medicine III, Cardiology and AngiologyMedical University of InnsbruckInnsbruckAustria
  3. 3.Department of Biomedical Engineering, Faculty of EngineeringLund UniversityLundSweden
  4. 4.Department of Cardiology, Clinical SciencesLund UniversityLundSweden
  5. 5.Department of Heart DiseaseHaukeland University HospitalBergenNorway
  6. 6.Department of BiomedicineUniversity of BergenBergenNorway
  7. 7.Department of Cardiology BOslo University Hospital Ullevål and University of OsloOsloNorway
  8. 8.Laboratory of Medical Informatics, School of MedicineAristotle University of ThessalonikiThessalonikiGreece
  9. 9.Section for Interventional Cardiology, Department of CardiologyOslo University HospitalUllevålNorway

Personalised recommendations